ClinicalTrials.gg
RecruitingNCT05169736Updated Jun 27, 2023

ICBT for Mental Health Problems Related to the Climate Crisis

An interventional study of Cognitive Behavioural Therapy in Depression and Quality of Life, sponsored by Linkoeping University. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-27.

Sponsored by Linkoeping University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Feb 2022; still recruiting 4 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Depression by Linkoeping University — 4 open to participants now, 7 under way, none of them phase 3. Depression · Linkoeping University.

Planned enrollment
8th of 27
120 · median 81
Started
2022
the only one that year
No phase
26 of 29
4 open now
Registered
20th of 29
by date

Among the 29 studies in Depression by Linkoeping University, this one is the 8th largest by planned enrollment of the 27 interventional ones that give a count, is the only one that started in 2022, is one of 26 with no phase, and was the 20th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

4 of the 29 studies in Depression by Linkoeping University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Depression by Linkoeping University, or all of them as a file.
02

Study summary

The study seeks to investigate the effects of a guided internet-based cognitive behavioral therapy (ICBT) programme on adult mental health problems related to the climate crisis. ICBT will be compared to a wait-list control group.

Participants will be recruited in Sweden with a nationwide recruitment.

Read the detailed description

The study is set up as a randomized controlled trial. Quality of life, depressive symptoms, anxiety, sleep problems and traumatic stress will be measured. Given uncertainties regarding the psychological effects connected to the climate crisis, a transproblematic tailored treatment approach will be used that has been tested in several previous trials. However, the present program has been adapted for the target population of people who are affected directly or indirectly by the societal and individual consequences of the climate crisis.

03

Conditions studied

  • Depression and Quality of Life

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Experience mental health problems that are caused or exacerbated by the climate crisis and/or its consequences 18 years or older. Adequate ability to understand and speak Swedish. Access to the internet and a smartphone/computer.

Exclusion criteria

Exclusion Criteria:

Other ongoing psychological treatment or counselling that interfere with trial treatment.

Recent (within the past 3 months) changes in the dose of psychotropic medication.

Any severe psychiatric or somatic conditions that would interfere with trial treatment

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Internet-based Cognitive Behavior Therapy

    ICBT, were participants receive 8 out of 15 possible modules, depending on their current problems and needs, 8 week long internet intervention for coping with mental health issues related to the climate crisis.

    Behavioral: Cognitive Behavioural Therapy

  • No intervention
    Wait-list control

    Participants in the control group will be instructed to wait. Once intervention group will be finished, participants in control group will be able to access the same intervention.

Interventions

  • BehavioralCognitive Behavioural Therapy

    Intervention based on cognitive behavioural therapy principles and adapted to mental health problems related to the climate crisis. Intervention's main purpose is to increase management of mental health issues such as depressive symtoms, stress, worry and anxiety related to the coronavirus pandemic and increase quality of life in the current situation. Intervention contains psycho-educational elements as well as examples and exercises.

06

What researchers measure

Primary outcomes

  1. Change in Becks Depression Inventory-II

    Measure of depressive symptoms. Possible range for the total sum: 0 to 63 (created by summing up the score from each item) with a higher score indicating a higher level of depressive symptoms. Clinical ranges for minimal, mild, moderate and severe major depressive disorder are considered to be 0-13, 13-19, 20-28, and 29-63 points.

    Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination

  2. Change in Perceived Stress Scale

    It is a measure of the degree to which situations in one's life are appraised as stressful. It contains 10 items that are scored on a range between 0 (never) to 4 (very often). The total score can range from 0-56 and a higher score reflects higher levels of perceived stress.

    Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.

  3. Change in Generalised Anxiety Disorder 7-item scale

    Seven item measure of generalized anxiety disorder. Sum score range from 0 to 21, with higher scores indicating more generalized anxiety. Cut-offs for interpretation: 0-5 minimal anxiety, 6-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.

    Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.

Secondary outcomes

  1. Change in Insomnia Severity Index

    Measure of insomnia severity and symptoms of disordered sleep. The total score can range between 0 (no sleep problems) to 28 (severe sleep problems and insomnia) with higher scores indicating severer levels of sleeping problems. Norm score ranges include low likelihood of sleep problems (0 to 7 points), some sleep problems (8 to 14 points), moderate sleep problems (15 to 21 points), severe sleep problems (22 to 28 points).

    Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.

  2. Change in Patient Health Questionnaire

    Measure of depressive symptoms. Possible range for the total sum: 0 to 27 (created by summing up the score from each item) with a higher score indicating higher levels of depression. Clinical cut-offs for mild, moderate, moderately severe and severe major depressive disorder are considered to be 5, 10, 15, and 20 points.

    Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.

  3. Change in Alcohol Use Disorder Identification Test

    The Alcohol Use Disorders Identification Test is a 10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems. 10 items and scores ranging from 0-40 with higher scores indicating a higher level of alcohol use.

    Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination.

  4. Change in ClimateCope Index (CCI)

    This scale was constructed by the research group, measuring coping strategies connected to the climate situations. It is a 33 item scale rating from 1 (not at all) to 5 (totally agree), with higher scores indicating more helpful coping strategies.

    Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination

  5. Change in Brunnsviken Brief Quality of Life Scale

    Measure of quality of life, total score ranging from 0 to 96 with a higher score indicating a higher quality of life. The scores of each of the six primary questions regarding perceived quality of life within an area of life are multiplied with the score of an item measuring the perceived importance of the area in question.

    Time frame: Baseline, 8 weeks and follow-up at 12 months after treatment termination

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2022 (actual). Primary completion is estimated for Jun 2024, 28 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 28 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 20, 2021
First posted
Dec 27, 2021
StartActual
Feb 7, 2022
Primary completionEst.
Jun 27, 2024
CompletionEst.
Jun 1, 2025
Last update
Jun 27, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05169736
Responsible party
Gerhard Andersson (Professor, Linkoeping University) — Principal investigator
First posted
Dec 27, 2021
Start date
Feb 7, 2022
Primary completion
Jun 27, 2024 (estimated)
Completion
Jun 1, 2025 (estimated)
Last update
Jun 27, 2023

Study contacts

Gerhard Andersson
Contact
gerhard.andersson@liu.se
+46709465357
Gerhard Andersson
principal investigator · Linkoeping University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion